Answer
Licensed uses are limited to defined CFTR mutations and combinations, so genotype confirmation determines eligibility.
Sources for this answer
- Kalydeco 50 mg granules in sachet — Current selected SmPCemc · Summary of Product Characteristics
- Kalydeco 75 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.